Access to Medicine: Pharmaceutical Patents and Public Health Needs Under the WTO Framework

DSpace/Manakin Repository

dc.contributor.advisor	Peter Hutt	en_US
dc.contributor.author	Liu, Kuanling
dc.date.accessioned	2012-07-06T22:06:28Z
dc.date.issued	2008
dc.identifier.citation	Kuanling Liu, Access to Medicine: Pharmaceutical Patents and Public Health Needs Under the WTO Framework (April 2008).	en_US
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965623
dc.description.abstract	Many people, particularly in developing countries, die from curable or manageable diseases without access to medicine. After the TRIPS Agreement was brought into force, access to medicine in developing countries became worse and even deteriorated development. To solve the controversy in interpreting the TRIPS Agreement and the resulting public health crises, the Doha Declaration was adopted, recognizing the flexibilities of the TRIPS Agreement as effective and vital manners to promote access to medicines. However, there are still many difficulties encountered by developing countries in full implementation of the Doha Declaration. Therefore, this paper aims to reexamine and reaffirm access to medicine as an international human right, claiming it should be accommodated under the WTO framework, and also proposes several possible solutions to advance the accessibility of medicine.	en_US
dash.license	LAA
dc.subject.other	Food and Drug Law	en_US
dc.title	Access to Medicine: Pharmaceutical Patents and Public Health Needs Under the WTO Framework	en_US
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-07-06T22:06:28Z

Files	Size	Format	View
Kuanling Liu Course and LLM work requirement.pdf	360.0Kb	PDF	View/Open